STAT3 and breast cancer: H53 also inhibited the PRL-induced phosphorylation of both STAT3 and STAT5, and AKT at a dose of 5-10 g/ml in T47D and MCF7 breast cancer cell lines, and further attenuated PRL-induced proliferation (100).